ALERE
DEAD

Serial Number

77837309

Owner

ALERE LLC

Filing Date

Sep 29, 2009

Add to watchlist:

No watchlists yet
View on USPTO

ALERE Trademark

Serial Number: 77837309 • Registration: 4760465

ALERE is a trademark filed by ALERE LLC on September 29, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ALERE LLC (38 trademarks)

3200 WINDY HILL ROAD
ATLANTA, GA 30339

Entity Type: 16

ALERE HEALTH, LLC (30 trademarks)

3200 WINDY HILL ROAD, SUITE B-100
ATLANTA, GA 30339

Entity Type: 16

Alere Medical, Inc. (6 trademarks)

10615 Professional Circle
Reno, NV 89521

Entity Type: 03

ALERE INC. (5 trademarks)

51 SAWYER ROAD, SUITE 200
WALTHAM, MA 02453

Entity Type: 03

Trademark Details

Filing Date

September 29, 2009

Registration Date

June 23, 2015

Published for Opposition

July 12, 2011

Cancellation Date

December 24, 2021

Goods & Services

Measuring devices, namely, fluorometers; electronic optical and electrochemical readers for use with medical diagnostic test kits; laboratory equipment, namely, culture tubes, test tubes, storage tubes, tube caps, pipettes, hand-operated laboratory presses for processing samples in preparation for analysis, and laboratory racks for containers for storing samples; laboratory equipment, namely, assay diagnostic slides; computer hardware; computer software that may be downloaded from computer networks for providing access to medical records; computer software for managing medical diagnostic test information; computer software in the healthcare field for managing data relating to the admission, treatment, discharge and invoicing of patients; computer software for providing access to medical case records via computer networks; computer software for transmitting electronic messages and data over computer networks in between different computer systems; computer software for scheduling medical appointments and appointments for use of medical equipment; computer software for generating medical staff duty rosters; computer software for managing data relating to medical research, laboratory test results and medical consultations; computer software for the extraction and analysis of statistical information

Chemical reagents for medical purposes; medical diagnostic reagents; reagents for medical use; chemical and biological antigens for medical diagnostic use; clinical medical reagents; pharmaceutical preparations for clinical research and genetic testing, namely, identifying birth defects and pregnancy disorders; diagnostic test kits consisting primarily of medical diagnostic chemicals and reagents; ovulation test kits; pregnancy test kits for home and medical use; cancer diagnostic test kits comprised primarily of reagents and assays for home and medical use for detecting cancers; medical diagnostic test kits comprised primarily of reagents and assays for testing bacterial vaginosis; medical diagnostic preparations and medical diagnostic reagents for home use; medical diagnostic test strips for home and medical use; medical diagnostic reagents and assays for testing bodily fluids; drug and alcohol testing kits for home and medical use comprised primarily of medical diagnostic reagents and assays for testing bodily fluids; drug testing device in the nature of drug testing cups containing a test strip for testing the presence of drugs in bodily fluids other than for medical purposes

Chemical preparations for scientific purposes; reagents for chemical analysis; chemical test paper; protein arrays and nucleotide arrays for scientific and medical research; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use; laboratory chemicals, namely, antibodies for use in scientific and medical research; laboratory chemicals, namely, fluorescent compound preparations for use in protein labeling in connection with scientific and medical research; laboratory chemicals, namely, gold liquid colloid solutions or sols for use in protein labeling in connection with scientific and medical research; assays for research purposes; chemicals, namely, buffer solutions used in analytical chemistry; laboratory chemicals, namely, control fluids for use in scientific and medical research; reagents for research purposes, namely, control reagents for use with scientific apparatus and instruments for use in scientific and medical research

Healthcare services; medical services; medical diagnostic testing, monitoring and reporting services; providing medical information; consulting and advisory services in the field of medical information; consulting services in the field of health; surgical services; blood bank services; providing health information; providing a website featuring medical information; providing a website featuring health and nutritional information and providing dietary and nutritional guidance; providing a website featuring medical information in the nature of health test results and health risk assessments; providing healthcare information via the Internet; medical services and medical physical evaluation services, namely, providing health screening services, health risk appraisals, personal health profiles, and health assessments for consumers, healthcare professionals, healthcare institutions; consulting in the field of medical testing for diagnostic and treatment purposes

Blood testing apparatus; electrochemical sensors for determination or analysis of analyte concentrates in blood and body fluids for medical purposes; medical diagnostic apparatus for testing the presence of alcohol in breath; medical diagnostic apparatus for testing the presence of drugs in body fluids, hair and breath; medical apparatus for detecting and measuring the level of drugs and alcohol in body fluids; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; medical apparatus and units for introducing pharmaceutical preparations into the body and for measuring drug dosages; medical apparatus and instruments for pregnancy testing, fertility monitoring, diagnosing and monitoring cardiovascular disease and detecting infectious diseases; medical diagnostic apparatus for use in monitoring and reporting data such as weight, blood pressure, pregnancy, ovulation, blood glucose levels, blood chemistry data, heart rate, EKG, coagulation time, peak flow and respiratory function in patients with diseases such as asthma, diabetes, obesity, hypertension, infectious diseases, cardio vascular disease, renal disease, cancer, and chronic obstructive pulmonary disease; medical instruments, namely, lances, lancets, lancing devices, syringes, hypodermic needles

Medical and scientific research; research and development in the field of pharmaceuticals and biotechnology, namely, in the field of antibodies and biochemical assays for diagnostic purposes; medical laboratories; medical and scientific research, namely, conducting clinical trials; IT consulting services; consulting services in the field of medical and healthcare technology; medical testing of blood; data mining; consulting in the field of product safety testing relating to medical diagnostic apparatus and instruments; providing an interactive website featuring technology enabling medical device users to exchange information with healthcare providers via a global computer network

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 24, 2021 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 23, 2020 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 11, 2018 TCCA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Nov 25, 2015 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Nov 4, 2015 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 1, 2015 ASCK
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2015 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 22, 2015 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 21, 2015 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 6, 2014 GNRN
NON-FINAL ACTION E-MAILED
Nov 6, 2014 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 6, 2014 CNRT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 23, 2014 ASGN
STATEMENT OF USE PROCESSING COMPLETE
Sep 3, 2014 SUPC
USE AMENDMENT FILED
Aug 28, 2014 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 28, 2014 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 14, 2014 EXRA
SOU EXTENSION 5 GRANTED
Feb 13, 2014 EX5G
SOU EXTENSION 5 FILED
Feb 3, 2014 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 3, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2013 EXRA
SOU EXTENSION 4 GRANTED
Jul 24, 2013 EX4G
SOU EXTENSION 4 FILED
Jul 22, 2013 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 22, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 24, 2013 EXRA
SOU EXTENSION 3 GRANTED
Jan 23, 2013 EX3G
SOU EXTENSION 3 FILED
Jan 9, 2013 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 9, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 18, 2012 EXRA
SOU EXTENSION 2 GRANTED
Jul 17, 2012 EX2G
SOU EXTENSION 2 FILED
Jul 13, 2012 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 13, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2012 EXRA
SOU EXTENSION 1 GRANTED
Feb 27, 2012 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 17, 2012 AITU
SOU EXTENSION 1 FILED
Jan 24, 2012 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 24, 2012 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2011 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Jul 20, 2011 CHPB
ASSIGNED TO PETITION STAFF
Jul 19, 2011 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 13, 2011 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2011 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 9, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2011 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 1, 2011 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2011 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2011 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2011 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 27, 2011 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 1, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 18, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 14, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 14, 2011 CRFA
ASSIGNED TO LIE
Feb 7, 2011 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 2, 2011 ERFR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 15, 2010 ASCK
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 4, 2010 GNFN
FINAL REFUSAL E-MAILED
Aug 4, 2010 GNFR
FINAL REFUSAL WRITTEN
Aug 4, 2010 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 15, 2010 TROA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 28, 2010 ASCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2010 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2010 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2010 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2009 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 7, 2009 ASGN
NEW APPLICATION ENTERED
Oct 2, 2009 NWAP